moxifloxacin has been researched along with nickel in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (nickel) | Trials (nickel) | Recent Studies (post-2010) (nickel) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 24,777 | 382 | 9,504 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djurdjevic, P; Ivanovic, N; Jakovljevic, I; Jelikic-Stankov, M; Joksovic, L | 1 |
| Aldred, KJ; Breland, EJ; Kerns, RJ; McPherson, SA; Osheroff, N; Turnbough, CL | 1 |
2 other study(ies) available for moxifloxacin and nickel
| Article | Year |
|---|---|
The effect of some fluoroquinolone family members on biospeciation of copper(II), nickel(II) and zinc(II) ions in human plasma.
Topics: Ciprofloxacin; Coordination Complexes; Copper; Fluoroquinolones; Humans; Ions; Levofloxacin; Moxifloxacin; Nickel; Ofloxacin; Zinc | 2014 |
Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge.
Topics: Alanine; Anti-Bacterial Agents; Bacillus anthracis; Cations, Divalent; Ciprofloxacin; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Manganese; Models, Molecular; Moxifloxacin; Mutation; Nickel; Protein Subunits; Recombinant Proteins; Topoisomerase Inhibitors; Valine; Water | 2014 |